Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

1,729 evidence items · page 22 / 70

72 %The pooled ART retention rate among people living with HIV in Nigeria was 72%.

NigeriaVIH/sidapublished 2024Journal of research in health sciencesPubMeddocument of 5 observations

5.2 %18 (5.2%) of the participants correctly responded that family should be involved in the physical care of the dying people living with HIV/AIDS.

NigeriaVIH/sidaobserved 2017published 2019PloS onePubMeddocument of 16 observations

27.1 %The prevalence of TB/HIV coinfection was highest in 2021 at 27.1%.

Nigeriatuberculose · VIH/sidaobserved 2021published 2024BMJ openPubMeddocument of 6 observations

10.8 yearsThe mean age of the HIV-infected children on HAART was 10.8 ± 4.3 years.

NigeriaVIH/sidapublished 2025African health sciencesPubMeddocument of 7 observations

Stigma and criminalization create barriers to health-care engagement and adherence to antiretroviral therapy (ART) among men who have sex with men (MSM) and transgender women (TGW) in sub-Saharan Africa.

NigeriaVIH/sidapublished 2019Antiviral therapyPubMeddocument of 6 observations

Antioxidant status was improved in the HIV-infected group on antiretroviral therapy (ART).

NigeriaVIH/sidapublished 2019BMC infectious diseasesPubMeddocument of 7 observations

0.4 %The prevalence of Cytomegalovirus (CMV) retinitis among persons living with HIV/AIDS in Osun State, Nigeria was 0.4%.

NigeriaCytomegalovirus (CMV) retinitis · VIH/sidapublished 2026BMC ophthalmologyPubMeddocument of 9 observations

4.3 %The prevalence of HIV among adolescents aged 10 to 19 years seeking healthcare services at the Federal Teaching Hospital, Birnin Kebbi, Nigeria, was 4.3% between January and June 2023.

NigeriaVIH/sidaobserved January and June 2023published 2025African journal of reproductive healthPubMeddocument of 4 observations

93 %Viral suppression among people living with HIV on antiretroviral therapy for ≥6 months was 93% during the COVID-19 pandemic (51,196/55,216) compared to 91% in the pre-COVID-19 period (43,336/47,728).

NigeriaVIH/sidaobserved during COVID-19published 2024PloS onePubMeddocument of 7 observations

50 %Fewer than half of facilities reported achieving rates of ≥90% completion of post-breastfeeding HIV testing for infants.

NigeriaVIH/sidapublished 2025Journal of the International Association of Providers of AIDS CarePubMeddocument of 3 observations

71 %Among 1598 female sex workers in Nigeria, 71.0% had HIV testing during their last pregnancy.

NigeriaVIH/sidapublished 2024International journal of STD & AIDSPubMeddocument of 12 observations

55.6 %Viral load suppression rates through adolescence and post-transition were 55.6%–64.0%.

NigeriaVIH/sidapublished 2020PloS onePubMeddocument of 7 observations

81.2 %Five hundred forty-nine (81.2%) of 676 tuberculosis patients at the TB DOTS clinic of Abubakar Tafawa Balewa University Teaching Hospital, Bauchi, from January 2017 to December 2021 were HIV negative.

NigeriaVIH/sidaobserved 2017 to 2021published 2024West African journal of medicinePubMeddocument of 14 observations

60.8 %60.8% of community-identified children living with HIV came from community-based index testing.

NigeriaVIH/sidapublished 2023BMC pediatricsPubMeddocument of 10 observations

1 individualsAmong those tested for HIV in the medical outreach in Durum community, Bauchi State, Nigeria, 1 (1%) had a positive result.

NigeriaVIH/sidaobserved 2023published 2023West African journal of medicinePubMeddocument of 11 observations

1,000 copies/mLThe intervention showed a significant effect on virologic control <1000 copies per milliliter (odds ratio = 1.42).

NigeriaVIH/sidapublished 2025Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 7 observations

37.5 %CRF02_AG was the major HIV-1 subtype, accounting for 37.5% of cases.

NigeriaVIH/sidaobserved 2009-12published 2016PloS onePubMeddocument of 14 observations

87.5 %Retention in care at 48 weeks was 87.5% among youth with HIV in Nigeria in a single-arm trial.

NigeriaVIH/sidapublished 2021Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 12 observations

0.12 %Among 2386 initially uninfected pregnant women in Nigeria followed until delivery, the seroconversion rate for HIV-HBV dual infection was 0.12%.

Nigeriahépatite B · VIH/sidapublished 2025Antiviral therapyPubMeddocument of 7 observations

Comprehensive HIV/AIDS knowledge remains low among young people in Nigeria.

NigeriaVIH/sidapublished 2025AIDS research and therapyPubMeddocument of 5 observations

159 casesThe study evaluated 159 cases of acquired drug resistance among persons living with HIV receiving combination antiretroviral therapy.

NigeriaVIH/sidaobserved 2004–2011published 2020AIDS research and therapyPubMeddocument of 7 observations

60 %The total knowledge score of HIV PEP among doctors was 60.0% with a standard deviation of 10.2%.

NigeriaVIH/sidapublished 2020West African journal of medicinePubMeddocument of 6 observations

12 %Low birth weight occurred in 12.0% of HIV-exposed babies and 13.5% of non-exposed babies.

NigeriaVIH/sidaobserved 2009-2015published 2019West African journal of medicinePubMeddocument of 4 observations

Adherence to Option B+ ART can reduce the risk of mother-to-child transmission (MTCT) of HIV to 1-2% as against 15-40% without treatment.

NigeriaVIH/sidapublished 2021The Pan African medical journalPubMeddocument of 5 observations

75.6 %75.6% of subjects receiving HIV treatment in private facilities in the Federal Capital Territory, Benue, and Nasarawa states in north-central Nigeria were virally suppressed.

NigeriaVIH/sidaobserved 2013–2019published 2022AIDS research and therapyPubMeddocument of 3 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.